Micah Berman is an associate professor of public health and law at The Ohio State University’s College of Public Health and Michael E. Moritz College of Law. His research explores the intersection between public health research and legal doctrine, and he is a co-author of The New Public Health Law: A Transdisciplinary Approach to Practice and Advocacy. He is currently funded by the National Cancer Institute to conduct research that supports the FDA’s regulation of tobacco, and by the Ohio Department of Medicaid to evaluate the impact of Ohio's Medicaid expansion.
Prior to joining Ohio State, Berman established and directed the Public Health and Tobacco Policy Center, which is now affiliated with Northeastern University School of Law. Under his leadership, the Center developed innovative model ordinances and provided policy support to state and local public health programs. Previously, he taught at Capital University Law School and directed the Ohio Tobacco Public Policy Center.
Professor Berman has also served as a senior advisor to the FDA’s Center for Tobacco Products and as a member of the NIH’s Council of Public Representatives.
Before discovering his passion for public health, Berman was a trial attorney with the U.S. Department of Justice’s Antitrust Division and an associate with the law firm Stinson Morrison Hecker LLP (now Stinson Leonard Street LLP). He received a JD with distinction from Stanford Law School and a BA with highest honors in Public Policy from Brandeis University.
Tobacco control and prevention, the intersection between public health research and legal doctrine
Scott Burris, Micah L. Berman, Matthew Penn, Tara Ramanathan Holiday, The New Public Health Law: A Transdisciplinary Approach to Practice and Advocacy (Oxford University Press and APHA Press, 2018).
Public Health Journals:
Berman ML; Zettler PJ; Ashley DA. Anticipating industry arguments: the FDA’s authority to reduce nicotine levels in cigarettes. Public Health Reports 2018;33(4):502-506.
Hemmerich N; Klein EG; Berman M. Evidentiary support in public comments to the FDA's Center for Tobacco Products. Journal of Health Politics, Policy and Law 2017;42(4):645-666.
Seiber EE; Berman ML. Medicaid expansion and ACA repeal: evidence from Ohio. American Journal of Public Health 2017;107(6):889-892.
Berman M. Regulatory oversight of ENDS product defects. Tobacco Control 2017;26(1):2-3.
Berman ML; Yang YT. E-cigarettes, youth, and FDA’s “deeming” regulation. JAMA Pediatrics 2016;170(11):1039-1040.
Wipfli H; Berman M; Hanson K; Kelder S; Solis A; Villanti AC; Ribeiro CMP; Meissner H; Anderson R. Defining tobacco regulatory science competencies. Nicotine & Tobacco Research 2017;19(2):222-230.
Peters E; Evans AT; Hemmerich N; Berman M. Emotion in the law and the lab: the case of graphic cigarette warnings. Tobacco Regulatory Science 2016;2(4):404-413.
Klein EG; Berman M; Hemmerich N; Htut S; Carlson C; Slater M. Online e-cigarette marketing claims: a systematic content and legal analysis. Tobacco Regulatory Science 2016;2(3):252-262.
Jenson D; Lester J; Berman ML. FDA’s misplaced priorities: premarket review under the Family Smoking Prevention and Tobacco Control Act. Tobacco Control 2016;25(3):246-253.
Berman ML. Raising the tobacco sales age to 21: surveying the legal landscape. Public Health Reports 2016;131:378-381.
Berman ML; Connolly G; Cummings MK; Djordjevic MV; Hatsukami DK; Henningfield JE; Myers M; O’Connor RJ; Parascandola M; Rees V; Rice JM; Shields PG. Providing a science base for the evaluation of tobacco products. Tobacco Regulatory Science 2015;1(1):76-93.
Berman M; Crane R; Seiber E; Munur M. Estimating the cost of a smoking employee. Tobacco Control 2014;23(5):428-433.
Patricia J. Zettler, Natalie Hemmerich & Micah L. Berman, Closing the Regulatory Gap for Synthetic Nicotine, 59 B.C. L. Rev. 1934 (2018).
Micah L. Berman, M. Justin Byron, Natalie Hemmerich, Eric N. Lindblom, Allison J. Lazard, Ellen Peters & Noel T. Brewer, Communicating Tobacco Product Information to the Public, 72 Food & Drug L.J. 386 (2017).
Micah L. Berman, Combining Accreditation and Education: An Interdisciplinary Public Health Law Course, 44 J. L. Med. & Ethics S18 (2016).
Micah L. Berman, Clarifying Standards for Compelled Commercial Speech, 40 Wash. U. J. L. & Pol’y 53 (2016).
Micah L. Berman, Manipulative Marketing and the First Amendment, 103 Geo. L.J. 497 (2015).
Micah L. Berman & Annice E. Kim, Bridging the Gap Between Science and Law: The Example of Tobacco Regulatory Science, 43 J.L. Med & Ethics S95 (2015).
Micah L. Berman, The Commercial Speech Doctrine in the United States: False Promises and Promising Approaches for Protecting Public Health, in Tobacco Advertising: The Front and Back Side of Free Commercial Speech (Adalberto Pasqualotto ed., 2015).